Erowid 2C-B vault—involves stories from end users of 2C-B, along with scientific and federal government reportsSerious complications immediately after coming down from substantial doses have been reported. Nevertheless, many consumers report a lack of "comedown" or "crash", alternatively noting a gradual return to sobriety;Pink copyright is usual